QuadraMed Health Information Management Products Rank First In Latest MD Buyline Report.RESTON, Va. -- QuadraMed(R) Corporation (Amex:QD) today announced that in the latest user satisfaction ratings published by MD Buyline, dated June 24, 2005, the QuadraMed Quantim(R) HIM (Health Information Management) product suite ranked number one, scoring 8.6 on a scale of ten, in the important composite rating. In five of the seven categories used to determine the composite rating - Applications Training, Installation/Implementation, Integration, Service and Support, and Product Flexibility - QuadraMed was also ranked number one. This "MD Buyline Intelligence Report," focused upon Medical Records Administration, noted that, "The patient's medical record is the critical source of information needed to deliver high quality patient care." Further stated in "The Market" analysis section, "The paper-based medical record is extremely inadequate for meeting the needs of modern medicine." "The composite rating clearly indicates that our service, support and implementation policies are right on target," said Laurie McBrierty, QuadraMed Vice President, HIM Solutions. "Further, our integrated web-native platform is proving to be the leading-edge technology HIM executives want to meet long-term challenges. From it, we have developed a vision for a paperless HIM department that is aligned with the AHIMA AHIMA American Health Information Management Association (Chicago, IL) (American Health Information Management Association The American Health Information Management Association (AHIMA) is a non-profit association for health information management professionals. The organization was founded in 1928, and has 51,000 members. ) e-HIM(TM) initiative." Quantim HIM products are designed by HIM professionals to provide the critical functionality and built-in workflow required to ensure maximum efficiency and accuracy. QuadraMed employs usability testing Usability testing is a means for measuring how well people can use some human-made object (such as a web page, a computer interface, a document, or a device) for its intended purpose, i.e. usability testing measures the usability of the object. conducted in cooperation with clients to ensure Quantim products meet or exceed user expectations in the real world. The benefits include lower A/R days, increased accuracy, greater patient satisfaction and full HIPAA (Health Insurance Portability & Accountability Act of 1996, Public Law 104-191) Also known as the "Kennedy-Kassebaum Act," this U.S. law protects employees' health insurance coverage when they change or lose their jobs (Title I) and provides standards for patient health, compliance, with anywhere, any time access. MD Buyline, headquartered in Dallas, Texas “Dallas” redirects here. For other uses, see Dallas (disambiguation). The City of Dallas (pronounced [ˈdæl.əs] or [ˈdæl. , was formed in 1983 and maintains the most comprehensive online database on medical technology and informatics Same as information technology and information systems. The term is more widely used in Europe. products, price and performance. The company's website can be accessed at www.mdbuyline.com. Further information about all QuadraMed products and services is available by visiting the website at www.quadramed.com or by calling 800-393-0278. About QuadraMed Corporation QuadraMed is dedicated to improving healthcare delivery by providing innovative healthcare information technology and services. From clinical and patient access management to revenue cycle and health information management, QuadraMed delivers real-world solutions that help healthcare professionals deliver outstanding patient care with optimum efficiency. Behind our products and services is a staff of almost 700 professionals whose experience and dedication to service have earned QuadraMed the trust and loyalty of customers at approximately 2,000 healthcare provider facilities. To find out more about QuadraMed, visit www.quadramed.com. Cautionary Statement on Risks Associated with QuadraMed's Forward-Looking Statements forward-looking statement A projected financial statement based on management expectations. A forward-looking statement involves risks with regard to the accuracy of assumptions underlying the projections. This press release contains forward-looking statements by QuadraMed within the meaning of the Private Securities Litigation Reform Act The Private Securities Litigation Reform Act of 1995 (PSLRA) implemented several significant substantive changes affecting certain cases brought under the federal securities laws, including changes related to pleading, discovery, liability, class representation and awards fees and of 1995 that are subject to risks and uncertainties. The words "believe," "expect," "anticipate," "intend," "plan," "estimate," "may," "should," "could," and similar expressions are intended to identify such statements. Forward-looking statements are not guarantees of future performance and are to be interpreted only as of the date on which they are made. QuadraMed undertakes no obligation to update or revise any forward-looking statement except as required by law. QuadraMed advises investors that it discusses risk factors and uncertainties that could cause QuadraMed's actual results to differ from forward-looking statements in its periodic reports filed with the Securities and Exchange Commission ("SEC"). QuadraMed's SEC filings can be accessed through the Investor Relations Investor relations The process by which the corporation communicates with its investors. section of our website, www.quadramed.com, or through the SEC's EDGAR Edgar or Eadgar (both: ĕd`gər), 943?–975, king of the English (959–75), son of Edmund, king of Wessex. In 957 the Mercians and Northumbrians rebelled against Edgar's brother Edwy and chose Edgar as their king. Database at www.sec.gov (QuadraMed has EDGAR CIK CIK Central Index Key (SEC) CIK Commission Internationale de Karting (French) CIK Crypto Ignition Key CIK Contribution in Kind CIK Confederazione Italiana Kendo No. 0001018833). QuadraMed and Quantim are registered trademarks of QuadraMed Corporation. All other trademarks are the property of their respective holders. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion